Literature DB >> 23050032

The "shield sign" in two men with metastatic salivary duct carcinoma to the skin: cutaneous metastases presenting as carcinoma hemorrhagiectoides.

Philip R Cohen1, Victor G Prieto, Sarina A Piha-Paul, Razelle Kurzrock.   

Abstract

BACKGROUND: Salivary duct carcinoma is an infrequent and highly aggressive cancer that rarely metastasizes to the skin. Inflammatory cutaneous metastatic carcinoma is characterized by tumor cells predominantly in dermal lymphatics (carcinoma erysipelatoides) or blood vessels (carcinoma telangiectoides).
PURPOSE: The authors present a distinctive cutaneous distribution of skin metastases from a visceral malignancy that resembles a medieval knight's shield and introduce a third pattern of inflammatory cutaneous metastatic carcinoma-carcinoma hemorrhagiectoides-which has a distinctive clinical presentation and pathological correlation.
METHODS: The authors describe the clinical and pathological characteristics of an unusual pattern of cutaneous metastases in two men with rapidly progressive salivary duct carcinoma and summarize the relevant literature. Immunoperoxidase stains with antibodies to CD31 and D2-40 were used to define the endothelial-lined dermal vessels containing tumor metastases: lymph vessels (CD31+/D2-40+) and blood vessels (CD31+/D2-40-).
RESULTS: Salivary duct carcinoma-related cutaneous metastases presented as large, violaceous, confluent, hemorrhagic and erythematous, dermal plaques across the chest and from the neck to the abdomen, reminiscent of a medieval knight's shield in two men. Microscopic examination demonstrated not only extensive infiltration of the dermis by tumor cells, but also tumor-containing endothelial-lined vessels: lymphatics (1 patient) or lymphatics and blood vessels (1 patient). Red blood cells were also noted in the tumor-filled lymph vessels of both patients.
CONCLUSION: Salivary duct carcinoma with cutaneous metastases is rare (five patients) and the most common skin sites of metastatic tumor were the neck and chest. In addition to carcinoma erysipelatoides and carcinoma telangiectoides, inflammatory cutaneous metastatic carcinoma also includes carcinoma hemorrhagiectoides (with metastatic tumor cells in dermal lymphatics, blood vessels, or both) in which the skin metastases clinically appear as purpuric violaceous indurated plaques and microscopically demonstrates moderate-to-extensive extravascular tumor infiltration in the dermis and hemorrhage of red blood cells into endothelial-lined lymph vessels. The distinctive pattern of cutaneous metastases in the patients described in this article, resembling a medieval knight's shield, has also been observed-albeit rarely-in patients with a primary malignancy of the parotid gland, thyroid, or unknown origin. Hence, the "shield sign" may be an uncommon presentation of tumors originating and/or metastasizing to the head and neck.

Entities:  

Year:  2012        PMID: 23050032      PMCID: PMC3460659     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  47 in total

Review 1.  Metastatic tumors to the nail unit: subungual metastases.

Authors:  P R Cohen
Journal:  Dermatol Surg       Date:  2001-03       Impact factor: 3.398

2.  Epidermoid cyst mimicry: report of seven cases and review of the literature.

Authors:  Jorge Garcia-Zuazaga; Malcolm S Ke; Marlene Willen
Journal:  J Clin Aesthet Dermatol       Date:  2009-10

3.  Violaceous plaques in a collarlike distribution--quiz case. Carcinoma erysipelatoides from carcinoma of unknown primary.

Authors:  Caroline E Schmitt; Krista J Childress; James S Feinberg
Journal:  Arch Dermatol       Date:  2011-03

4.  [Salivary duct carcinoma. A group of salivary gland tumors analogous to mammary duct carcinoma].

Authors:  O Kleinsasser; H J Klein; G Hübner
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1968

5.  Telangiectatic metastasis from ductal carcinoma of the parotid gland.

Authors:  A Zanca; U Ferracini; M G Bertazzoni
Journal:  J Am Acad Dermatol       Date:  1993-01       Impact factor: 11.527

6.  Expression of androgen receptor in breast cancer and its significance as a prognostic factor.

Authors:  Q Yu; Y Niu; N Liu; J Z Zhang; T J Liu; R J Zhang; S L Wang; X M Ding; X Q Xiao
Journal:  Ann Oncol       Date:  2010-11-25       Impact factor: 32.976

Review 7.  Cutaneous metastases of visceral tumours: a review.

Authors:  Dorothée Nashan; Marcel Lucas Müller; Markus Braun-Falco; Sebastian Reichenberger; Rolf-Markus Szeimies; Leena Bruckner-Tuderman
Journal:  J Cancer Res Clin Oncol       Date:  2008-06-17       Impact factor: 4.553

8.  Clinical implications of esophagorespiratory fistulae in patients with esophageal squamous cell carcinoma (SCCA).

Authors:  Moon Ki Choi; Yeon Hee Park; Jung Yong Hong; Hee Chul Park; Yong Chan Ahn; Kwanmien Kim; Yong-Mok Shim; Won Ki Kang; Keunchil Park; Young-Hyuck Im
Journal:  Med Oncol       Date:  2009-11-19       Impact factor: 3.064

9.  Zosteriform and epidermotropic metastasis. Report of two cases.

Authors:  A Manteaux; P R Cohen; R P Rapini
Journal:  J Dermatol Surg Oncol       Date:  1992-02

10.  Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival.

Authors:  Fredrik Petersson; A Hafeez Diwan; Doina Ivan; Jeffrey E Gershenwald; Marcella M Johnson; Robyn Harrell; Victor G Prieto
Journal:  J Cutan Pathol       Date:  2009-02-05       Impact factor: 1.587

View more
  2 in total

1.  Cutaneous Metastases from Salivary Duct Carcinoma of the Submandibular Gland.

Authors:  Wahida Chakari; Luise Andersen; Jørgen Lock Andersen
Journal:  Case Rep Dermatol       Date:  2017-12-05

Review 2.  Cutaneous Metastatic Cancer: Carcinoma Hemorrhagiectoides Presenting as the Shield Sign.

Authors:  Philip R Cohen; Razelle Kurzrock
Journal:  Cureus       Date:  2021-01-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.